CardioExchange Archive

CardioExchange is dedicated to bringing you the latest from ACC.14. Check out our coverage of the conference ─ and some of the great debates these posts have sparked ─ then tell us what you think!

News:

• No Benefit Found in First Real Test of Renal Denervation

• Survival Advantage for TAVR Over Surgery in High-Risk Patients

• First TAVR Comparison Trial Favors Sapien XT Over CoreValve

• MADIT-CRT Long-Term Follow-Up Shows Survival Benefit with CRT-D

• High-Sensitivity Troponin Test Could Identify Low-Risk Chest Pain Patients in the ED

• Aspirin and Clonidine Fail to Help Surgery Patients

• Novartis Trial Was Stopped Early Because of a Significant Drop in Cardiovascular Mortality

Analysis:

• Negative Findings on Renal Denervation for Hypertension: Sweet SYMPLICITY?

• TAVR: Are You Impressed Now?

• Long-Term Follow-Up from MADIT-CRT: Guideline Implications

• Are We Equipped to Make a CHOICE Between TAVR Devices?

Follow our Fellows:

• Changing My Priorities for ACC.14

• Ideals Lost, But Not Stolen

• Are Digital Conferences the Way of the Future?

• Taking Patient-Centerdness to the Next Level at ACC.14

• Stage Set for Phase IV Trials of PCSK9 Inhibition

• Master of all Trades